Acid aspiration-induced airways hyperresponsiveness in mice

Journal of Applied Physiology

Volumn 107, Issue 6, 2009, Pages 1763-1770

  Allen, Gilman B ^a,b   Leclair, Timothy R ^a   Von Reyn, Jessica ^a   Larrabee, Yuna C ^a   Cloutier, Mary E ^a   Irvin, Charles G ^a,b   Bates, Jason H T ^a,b  

^a UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

Author keywords

Asthma; Forced oscillations; Gastroesophageal reflux; Lung mechanics; Respiratory impedance

Indexed keywords

ADMINISTRATION, INHALATION; AEROSOLS; ANALYSIS OF VARIANCE; ANIMALS; BRONCHIAL HYPERREACTIVITY; BRONCHOALVEOLAR LAVAGE; BRONCHOALVEOLAR LAVAGE FLUID; CELL COUNT; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROCARDIOGRAPHY; FEMALE; HEART RATE; HYDROCHLORIC ACID; INFLAMMATION; METHACHOLINE CHLORIDE; MICE; MICE, INBRED BALB C; RESPIRATORY MECHANICS; TIME FACTORS;

EID: 73449142505     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00572.2009     Document Type: Article

References (54)

1. Allen GB, Cloutier ME, Larrabee YC, Tetenev K, Smiley ST, Bates JH. Neither fibrin nor plasminogen activator inhibitor-1 deficiency protects lung function in a mouse model of acute lung injury. Am J Physiol Lung Cell Mol Physiol 296: L277-L285, 2009.
2. Allen GB, Leclair T, Cloutier M, Thompson-Figueroa J, Bates JH. The response to recruitment worsens with progression of lung injury and fibrin accumulation in a mouse model of acid aspiration. Am J Physiol Lung Cell Mol Physiol 292: L1580-L1589, 2007.
3. Allen GB, Pavone LA, DiRocco JD, Bates JHT, Nieman GF. Pulmonary impedance and alveolar instability during injurious ventilation in rats. J Appl Physiol 99: 723-730, 2005.
4. Allen GB, Suratt BT, Rinaldi L, Petty JM, Bates JH. Choosing the frequency of deep inflation in mice: balancing recruitment against ventilator-induced lung injury. Am J Physiol Lung Cell Mol Physiol 291: L710-L717, 2006.
5. Bates JH, Cojocaru A, Haverkamp HC, Rinaldi LM, Irvin CG. The synergistic interactions of allergic lung inflammation and intratracheal cationic protein. Am J Respir Crit Care Med 177: 261-268, 2008.
6. Bates JH, Wagers SS, Norton RJ, Rinaldi LM, Irvin CG. Exaggerated airway narrowing in mice treated with intratracheal cationic protein. J Appl Physiol 100: 500-506, 2006.
7. Cassidy KJ, Halpern D, Ressler BG, Grotberg JB. Surfactant effects in model airway closure experiments. J Appl Physiol 87: 415-427, 1999.
8. Chambers LS, Black JL, Ge Q, Carlin SM, Au WW, Poniris M, Thompson J, Johnson PR, Burgess JK. PAR-2 activation, PGE2, and COX-2 in human asthmatic and nonasthmatic airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol 285: L619-L627, 2003.
9. Chernow B, Castell DO. Asthma and gastroesophageal reflux. JAMA 237: 2379, 1977.
10. Crapo RO, Casaburi R, Coates AL, Enright PL, Hankinson JL, Irvin CG, MacIntyre NR, McKay RT, Wanger JS, Anderson SD, Cockcroft DW, Fish JE, Sterk PJ. Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med 161: 309-329, 2000.
11. Davidson BA, Knight PR, Wang Z, Chess PR, Holm BA, Russo TA, Hutson A, Notter RH. Surfactant alterations in acute inflammatory lung injury from aspiration of acid and gastric particulates. Am J Physiol Lung Cell Mol Physiol 288: L699-L708, 2005.
12. Depla AC, Bartelsman JF, Roos CM, Tytgat GN, Jansen HM. Beneficial effect of omeprazole in a patient with severe bronchial asthma and gastro-oesophageal reflux. Eur Respir J 1: 966-968, 1988.
13. Fackler WK, Ours TM, Vaezi MF, Richter JE. Long-term effect of H2RA therapy on nocturnal gastric acid breakthrough. Gastroenterology 122: 625-632, 2002.
14. Frank JA, Gutierrez JA, Jones KD, Allen L, Dobbs L, Matthay MA. Low tidal volume reduces epithelial and endothelial injury in acid-injured rat lungs. Am J Respir Crit Care Med 165: 242-249, 2002.
15. Fredberg JJ. Bronchospasm and its biophysical basis in airway smooth muscle. Respir Res 5: 2, 2004.
16. Goldman G, Welbourn R, Kobzik L, Valeri CR, Shepro D, Hechtman HB. Reactive oxygen species and elastase mediate lung permeability after acid aspiration. J Appl Physiol 73: 571-575, 1992.
17. Gunnbjornsdottir MI, Omenaas E, Gislason T, Norrman E, Olin AC, Jogi R, Jensen EJ, Lindberg E, Bjornsson E, Franklin K, Janson C, Gulsvik A, Laerum B, Svanes C, Toren K, Tunsater A, Lillienberg L, Gislason D, Blondal T, Bjornsdottir US, Jorundsdottir KB, Talvik R, Forsberg B, Franklin K, Lundback B, Soderberg M, Ledin MC, Boman G, Norback D, Wieslander G, Spetz-Nystrom U, Cashelunge KS, Ryden E. Obesity and nocturnal gastro-oesophageal reflux are related to onset of asthma and respiratory symptoms. Eur Respir J 24: 116 -121, 2004.
18. Han X, Fink MP, Uchiyama T, Yang R, Delude RL. Increased iNOS activity is essential for pulmonary epithelial tight junction dysfunction in endotoxemic mice. Am J Physiol Lung Cell Mol Physiol 286: L259-L267, 2004.
19. Hantos Z, Daroczy B, Suki B, Nagy S, Fredberg JJ. Input impedance and peripheral inhomogeneity of dog lungs. J Appl Physiol 72: 168-178, 1992.
20. Harding SM, Guzzo MR, Richter JE. 24-h esophageal pH testing in asthmatics: respiratory symptom correlation with esophageal acid events. Chest 115: 654-659, 1999.
21. Harding SM, Guzzo MR, Richter JE. The prevalence of gastroesophageal reflux in asthma patients without reflux symptoms. Am J Respir Crit Care Med 162: 34-39, 2000.
22. Harding SM, Richter JE. The role of gastroesophageal reflux in chronic cough and asthma. Chest 111: 1389-1402, 1997.
23. Harding SM, Richter JE, Guzzo MR, Schan CA, Alexander RW, Bradley LA. Asthma and gastroesophageal reflux: acid suppressive therapy improves asthma outcome. Am J Med 100: 395-405, 1996.
24. Harper PC, Bergner A, Kaye MD. Antireflux treatment for asthma. Improvement in patients with associated gastroesophageal reflux. Arch Intern Med 147: 56-60, 1987.
25. Heil M, Hazel AL, Smith JA. The mechanics of airway closure. Respir Physiol Neurobiol 163: 214-221, 2008.
26. Homma T, Bates JH, Irvin CG. Airway hyperresponsiveness induced by cationic proteins in vivo: site of action. Am J Physiol Lung Cell Mol Physiol 289: L413-L418, 2005.
27. Irwin RS, Baumann MH, Bolser DC, Boulet LP, Braman SS, Brightling CE, Brown KK, Canning BJ, Chang AB, Dicpinigaitis PV, Eccles R, Glomb WB, Goldstein LB, Graham LM, Hargreave FE, Kvale PA, Lewis SZ, McCool FD, McCrory DC, Prakash UB, Pratter MR, Rosen MJ, Schulman E, Shannon JJ, Smith Hammond C, Tarlo SM. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest 129: 1S-23S, 2006.
28. Irwin RS, Curley FJ, French CL. Difficult-to-control asthma. Contributing factors and outcome of a systematic management protocol. Chest 103: 1662-1669, 1993.
29. Jack CI, Calverley PM, Donnelly RJ, Tran J, Russell G, Hind CR, Evans CC. Simultaneous tracheal and oesophageal pH measurements in asthmatic patients with gastro-oesophageal reflux. Thorax 50: 201-204, 1995.
30. Joish VN, Donaldson G, Stockdale W, Oderda GM, Crawley J, Sasane R, Joshua-Gotlib S, Brixner DI. The economic impact of GERD and PUD: examination of direct and indirect costs using a large integrated employer claims database. Curr Med Res Opin 21: 535-544, 2005.
31. Kaczka DW, Ingenito EP, Israel E, Lutchen KR. Airway and lung tissue mechanics in asthma. Effects of albuterol. Am J Respir Crit Care Med 159: 169-178, 1999.
32. Katz PO, Koch FK, Ballard ED, Bagin RG, Gautille TC, Checani GC, Hogan DL, Pratha VS. Comparison of the effects of immediate-release omeprazole oral suspension, delayed-release lansoprazole capsules and delayed-release esomeprazole capsules on nocturnal gastric acidity after bedtime dosing in patients with night-time GERD symptoms. Aliment Pharmacol Ther 25: 197-205, 2007.
33. Kennedy TP, Johnson KJ, Kunkel RG, Ward PA, Knight PR, Finch JS. Acute acid aspiration lung injury in the rat: biphasic pathogenesis. Anesthesia Analgesia 69: 87-92, 1989.
34. Kinoshita Y, Sato S. Burden and cost of treatment for GERD. J Gastroenterol 40: 1083-1084, 2005.
35. Knight PR, Druskovich G, Tait AR, Johnson KJ. The role of neutrophils, oxidants, and proteases in the pathogenesis of acid pulmonary injury. Anesthesiology 77: 772-778, 1992.
36. Knight PR, Rutter T, Tait AR, Coleman E, Johnson K. Pathogenesis of gastric particulate lung injury: a comparison and interaction with acidic pneumonitis. Anesthesia Analgesia 77: 754-760, 1993.
37. Lauzon AM, Bates JH. Kinetics of respiratory system elastance after airway challenge in dogs. J Appl Physiol 89: 2023-2029, 2000.
38. Leclair TR, Bates JHT, Allen GB. Airways hyperresponsiveness in a mouse model of aspiration injury (Abstract). Am J Respir Crit Care Med 137: A823, 2006.
39. Leclair TR, Cojocaru A, Bates JHT, Allen GB. Airways hyperresponsiveness in a mouse model of aspiration injury due to bronchial epithelial barrier disruption (Abstract). Am J Respir Crit Care Med 175: A155, 2007.
40. Lundblad LK, Thompson-Figueroa J, Allen GB, Rinaldi L, Norton RJ, Irvin CG, Bates JH. Airway hyperresponsiveness in allergically inflamed mice: the role of airway closure. Am J Respir Crit Care Med 175: 768-774, 2007.
41. Mansfield LE, Stein MR. Gastroesophageal reflux and asthma: a possible reflex mechanism. Ann Allergy 41: 224-226, 1978.
42. Mastronarde JG, Anthonisen NR, Castro M, Holbrook JT, Leone FT, Teague WG, Wise RA. Efficacy of esomeprazole for treatment of poorly controlled asthma. N Engl J Med 360: 1487-1499, 2009.
43. Miehlke S, Madisch A, Kirsch C, Lindner F, Kuhlisch E, Laass M, Knoth H, Morgner A, Labenz J. Intragastric acidity during treatment with esomeprazole 40 mg twice daily or pantoprazole 40 mg twice daily: a randomized, two-way crossover study. Aliment Pharmacol Ther 21: 963-967, 2005.
44. Ours TM, Fackler WK, Richter JE, Vaezi MF. Nocturnal acid breakthrough: clinical significance and correlation with esophageal acid exposure. Am J Gastroenterol 98: 545-550, 2003.
45. Ricciardolo FL, Steinhoff M, Amadesi S, Guerrini R, Tognetto M, Trevisani M, Creminon C, Bertrand C, Bunnett NW, Fabbri LM, Salvadori S, Geppetti P. Presence and bronchomotor activity of protease-activated receptor-2 in guinea pig airways. Am J Respir Crit Care Med 161: 1672-1680, 2000.
46. Seeger W, Grube C, Gunther A, Schmidt R. Surfactant inhibition by plasma proteins: differential sensitivity of various surfactant preparations. Eur Respir J 6: 971-977, 1993.
47. Sharma A, Goh HL, Asokananthan N, Bakker A, Stewart GA, Mitchell HW. Delayed and persistent suppression of bronchoconstriction by trypsin in the airway lumen. Eur Respir J 27: 20-28, 2006.
48. Sontag SJ, O'Connell S, Khandelwal S, Miller T, Nemchausky B, Schnell TG, Serlovsky R. Most asthmatics have gastroesophageal reflux with or without bronchodilator therapy. Gastroenterology 99: 613-620, 1990.
49. Sterk PJ, Bel EH. Bronchial hyperresponsiveness: the need for a distinction between hypersensitivity and excessive airway narrowing. Eur Respir J 2: 267-274, 1989.
50. Stordal K, Johannesdottir GB, Bentsen BS, Knudsen PK, Carlsen KC, Closs O, Handeland M, Holm HK, Sandvik L. Acid suppression does not change respiratory symptoms in children with asthma and gastrooesophageal reflux disease. Arch Dis Child 90: 956-960, 2005.
51. Venglarik CJ, Giron-Calle J, Wigley AF, Malle E, Watanabe N, Forman HJ. Hypochlorous acid alters bronchial epithelial cell membrane properties and prevention by extracellular glutathione. J Appl Physiol 95: 2444-2452, 2003.
52. Vincent D, Cohen-Jonathan AM, Leport J, Merrouche M, Geronimi A, Pradalier A, Soule JC. Gastro-oesophageal reflux prevalence and relationship with bronchial reactivity in asthma. Eur Respir J 10: 2255-2259, 1997.
53. Welsh MJ, Shasby DM, Husted RM. Oxidants increase paracellular permeability in a cultured epithelial cell line. J Clin Invest 76: 1155-1168, 1985.
54. Wong CH, Chua CJ, Liam CK, Goh KL. Gastro-oesophageal reflux disease in 'difficult-to-control' asthma: prevalence and response to treatment with acid suppressive therapy. Aliment Pharmacol Ther 23: 1321-1327, 2006.